Tango Therapeutics, Inc. (TNGX): Price and Financial Metrics
TNGX Price/Volume Stats
Current price | $5.16 | 52-week high | $13.01 |
Prev. close | $5.15 | 52-week low | $5.07 |
Day low | $5.07 | Volume | 2,306,400 |
Day high | $5.30 | Avg. volume | 788,477 |
50-day MA | $8.04 | Dividend yield | N/A |
200-day MA | $8.91 | Market Cap | 552.86M |
TNGX Stock Price Chart Interactive Chart >
Tango Therapeutics, Inc. (TNGX) Company Bio
Tango Therapeutics, Inc., a biotechnology company, discovers and develops medicines for the treatment of cancer. Its lead program is TNG908, a protein arginine methyl transferase 5 inhibitor that is being developed as a treatment for cancers with MTAP deletions. The company also develops Ubiquitin-specific protease 1, an inhibitor that treats cancers with BRCA1 mutations. Tango Therapeutics, Inc. has strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is based in Cambridge, Massachusetts.
TNGX Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...